271 related articles for article (PubMed ID: 25356020)
1. Hepatitis B virus and hepatitis C virus dual infection.
Caccamo G; Saffioti F; Raimondo G
World J Gastroenterol; 2014 Oct; 20(40):14559-67. PubMed ID: 25356020
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus/Hepatitis B virus coinfection: Current prospectives.
Maqsood Q; Sumrin A; Iqbal M; Younas S; Hussain N; Mahnoor M; Wajid A
Antivir Ther; 2023 Aug; 28(4):13596535231189643. PubMed ID: 37489502
[TBL] [Abstract][Full Text] [Related]
3. Clinical and therapeutical importance of HBV genotyping in Romania.
Constantinescu I; Nedelcu F; Toader MA; Daniela V
J Med Life; 2008; 1(2):165-73. PubMed ID: 20108463
[TBL] [Abstract][Full Text] [Related]
4. Natural history of chronic hepatitis B: phases in a complex relationship.
Croagh CM; Lubel JS
World J Gastroenterol; 2014 Aug; 20(30):10395-404. PubMed ID: 25132755
[TBL] [Abstract][Full Text] [Related]
5. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.
Songtanin B; Chaisrimaneepan N; Mendóza R; Nugent K
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675959
[TBL] [Abstract][Full Text] [Related]
6. Australian consensus recommendations for the management of hepatitis B.
Lubel JS; Strasser SI; Thompson AJ; Cowie BC; MacLachlan J; Allard NL; Holmes J; Kemp WW; Majumdar A; Iser D; Howell J; Matthews GV
Med J Aust; 2022 May; 216(9):478-486. PubMed ID: 35249220
[TBL] [Abstract][Full Text] [Related]
7. 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations.
Yu ML; Chen PJ; Dai CY; Hu TH; Huang CF; Huang YH; Hung CH; Lin CY; Liu CH; Liu CJ; Peng CY; Lin HC; Kao JH; Chuang WL
J Formos Med Assoc; 2020 Jul; 119(7):1135-1157. PubMed ID: 32354689
[TBL] [Abstract][Full Text] [Related]
8. [New progress on diagnosis and treatment for indeterminate-phase chronic hepatitis B virus-infected patients].
Liu JC; Wu C; Li J
Zhonghua Gan Zang Bing Za Zhi; 2024 Apr; 32(4):370-374. PubMed ID: 38733194
[TBL] [Abstract][Full Text] [Related]
9. Viral-Associated GN: Hepatitis B and Other Viral Infections.
Kupin WL
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1529-1533. PubMed ID: 27797900
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma: A global view.
Yang JD; Roberts LR
Nat Rev Gastroenterol Hepatol; 2010 Aug; 7(8):448-58. PubMed ID: 20628345
[TBL] [Abstract][Full Text] [Related]
11. Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?
Di Dato F; Iorio R
World J Gastroenterol; 2024 May; 30(17):2294-2297. PubMed ID: 38813053
[TBL] [Abstract][Full Text] [Related]
12. HIV/HBV coinfection: understanding the complex interactions and their impact on spontaneous HBV clearance, chronic liver damage, cirrhosis, and hepatocellular carcinoma.
Xiao J; Zhang Y; Wu J; -Chen X; Zou W
AIDS Rev; 2024; 26(1):32-40. PubMed ID: 38530710
[TBL] [Abstract][Full Text] [Related]
13. Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma.
Alqahtani SA; Colombo M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831314
[TBL] [Abstract][Full Text] [Related]
14. RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus.
Kincaid RP; Lam VL; Chirayil RP; Randall G; Sullivan CS
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8197-8202. PubMed ID: 30038017
[TBL] [Abstract][Full Text] [Related]
15. SASLT guidelines: Update in treatment of hepatitis C virus infection, 2024.
Alghamdi AS; Alghamdi H; Alserehi HA; Babatin MA; Alswat KA; Alghamdi M; AlQutub A; Abaalkhail F; Altraif I; Alfaleh FZ; Sanai FM
Saudi J Gastroenterol; 2024 Jan; 30(Supp 1):S1-S42. PubMed ID: 38167232
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology.
Strazzabosco M; Cortesi PA; Conti S; Okolicsanyi S; Rota M; Ciaccio A; Cozzolino P; Fornari C; Gemma M; Scalone L; Cesana G; Fabris L; Colledan M; Fagiuoli S; Ideo G; Zavaglia C; Perricone G; Munari LM; Mantovani LG; Belli LS
Liver Int; 2020 Jan; 40(1):60-73. PubMed ID: 31654608
[TBL] [Abstract][Full Text] [Related]
17. The public health challenge of liver cancer in Mongolia.
Znaor A; Chimed T; Laversanne M; Tudev U; Sanjaajamts E; Sandagdorj T; Bray F
Lancet Gastroenterol Hepatol; 2018 Oct; 3(10):660-662. PubMed ID: 30215354
[No Abstract] [Full Text] [Related]
18. The intersection of virus infection and liver disease: A comprehensive review of pathogenesis, diagnosis, and treatment.
Ren M; Lu C; Zhou M; Jiang X; Li X; Liu N
WIREs Mech Dis; 2024; 16(3):e1640. PubMed ID: 38253964
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015.
Kasting ML; Giuliano AR; Reich RR; Roetzheim RG; Nelson DR; Shenkman E; Vadaparampil ST
Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):503-513. PubMed ID: 29588306
[No Abstract] [Full Text] [Related]
20. HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases.
Cheng Z; Lin P; Cheng N
Front Med (Lausanne); 2021; 8():713981. PubMed ID: 34676223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
